JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


*277 !**	Tue, 8/2/2011, 8:30 AM - 10:20 AM	CC-A201
Recent Developments in Addressing Multiplicity Issues in Clinical Trials — Invited Papers
Biopharmaceutical Section , Section on Health Policy Statistics , Scientific and Public Affairs Advisory Committee , Section for Statistical Programmers and Analysts
Organizer(s): Mohamed A. Alosh, U.S. Food and Drug Administration
Chair(s): Mohamed A. Alosh, U.S. Food and Drug Administration
8:35 AM	Graphical Approaches to Multiple Test Procedures — Frank Bretz, Novartis Pharma AG
8:55 AM	Weighted Multiple Comparisons Procedures for Clinical Trials — Brian L. Wiens, Alcon Laboratories, Inc. ; Alex Dmitrienko, Eli Lilly and Company
9:15 AM	Use of Prior Information for Improving the Power of Multiple Testing Procedures — Mohammad Huque, U.S. Food and Drug Administration ; Mohamed A. Alosh, U.S. Food and Drug Administration
9:35 AM	Testing Individual Hypothesis Marginally at 0.05 Without Inflation of the Family-Wise Error Rate — David Li, Pfizer Inc.
9:55 AM	Discussant: Ralph B. D'Agostino Sr., Boston University
10:15 AM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.